Figure 2.
Overall survival (left) and progression-free survival (right) of 64 chemoresistant Hodgkin’s lymphoma patients treated with high-dose therapy and autologous transplantation stratified by year of transplant.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.